Strona główna・Stock List・Bruker Corp

Bruker Corp

Closed

SectorHealthcare

53.41 4.44

Buy Sell

Overview

Share price change

24h

Current

Min

50.76

Max

52.62

Key metrics
By Trading Economics
Income	-14M 16M
Sales	-154M 823M
EPS	0.31
Dividend yield	0.32
Profit margin	1.907
Employees	11,085
EBITDA	-45M 89M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+5.45% upside

Dividends
By Acuity
Dividend yield Sector Avg	0.32% 2.29%
Next Earnings	2 lis 2026
Next Dividend date	2 paź 2026
Next Ex Dividend date	22 wrz 2026

Market Stats
By TradingEconomics
Market Cap	4.3B 9.8B
Previous open	48.97
Previous close	53.41

News Sentiment

By Acuity

18%

82%

37 / 340 Ranking in Healthcare

Bruker Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 sie 2026, 19:11 UTC

News

Correlated Moves

BRKR rises as JPMorgan raises target to $42.00.

4 sie 2026, 23:41 UTC

News

Bruker shares higher in after-market hours following Jefferies' price target increase to $62.00, maintaining a Buy rating amid broader performance challenges.

3 sie 2026, 23:46 UTC

Bruker Corp shares declined slightly in after-market trading, fluctuating within a narrow range while remaining above the 20-day moving average.

31 lip 2026, 19:36 UTC

Bruker Corp shares are lower today, having reached a session low earlier. The stock remains above its 20-day moving average.

30 lip 2026, 19:18 UTC

Bruker Corp shares are higher, reflecting market strength amid a broader recovery. The stock trades well above its 20-day moving average.

29 lip 2026, 18:43 UTC

Bruker Corp shares are lower Wednesday amid rising crude oil prices and geopolitical tensions, following a session high shortly after the market opened.

28 lip 2026, 19:03 UTC

Correlated Moves

Bruker Corp is trading higher, buoyed by gains in the Life Sciences Tools & Services sector and a significant rise in correlated asset IQVIA Holdings.

27 lip 2026, 19:46 UTC

Bruker Corp shares are lower today amid broader market trends influenced by a notable decline in crude oil prices following eased geopolitical tensions.

24 lip 2026, 17:36 UTC

Bruker Corp shares are lower today amid notable volatility and no specific news. Market dynamics reflect a significant pullback in crude oil prices.

22 lip 2026, 15:46 UTC

Bruker Corp shares are lower today, with no specific news identified. Broader market dynamics, including rising crude oil prices, may be influencing sentiment.

21 lip 2026, 20:02 UTC

Bruker Corp shares are higher today, reflecting strong market performance amid renewed interest in technology and AI stocks ahead of major earnings reports.

20 lip 2026, 19:02 UTC

Bruker Corp shares are lower today, breaking a trend of higher closes. No specific news was identified to explain the decline.

Peer Comparison

Price change

Bruker Corp Forecast

Price Target

By TipRanks

5.45% upside

12 Months Forecast

Average 55.33 USD 5.45%

High 70 USD

Low 40 USD

Based on 11 Wall Street analysts offering 12 month price targets forBruker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Bruker Corp - Dist in the past 3 months.

Sentiment

By Acuity

37 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.